Current Issue

View Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 1

Robert Dream, Managing Director, HDR Company LLC

From Destructive to Digital: Automating Tablet Quality Control for Advanced Manufacturing

Andrew Anderson, CEO, Squared Consultancy Anna Codina, Senior Director Strategy & Busi...

Enabling Comprehensive Data Analytics and Process Monitoring in Bio-manufacturing Key Succ...

Robert Dimitri, Director, Systems and Data Integration, DynamixE, Inc. (Previously Associa...

New Paradigm of Building Quality during Manufacture – Challenges with Biological Product...

Rajesh K. Gupta, Ph.D., President and Principal Consultant, Biologics Quality & Regul...

Comparison of purification performance of Amsphere A3 to other commercially available Prot...

JSR Life Sciences

Featured Articles

Enabling Total Biopharma Solutions

Pall Life Sciences

Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems

Coupling single-pass TFF before loading onto a chromatography sorbent

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

View All Featured Articles

Careers

Delivering Better Outcomes for Patients Starts with Creating a Workplace Where all Colleagues Can Thrive

Ahmed Elhusseiny, Roche Pharmaceuticals, Area Head, Asia Pacific

Amgen is a Company that Cares about People, I Feel Genuinely Listened to Here

Jason Rudd, Amgen, Statistical Programming Manager

Inspiring the Next Generation at Bristol Myers Squibb

Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist

A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza

Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development

At Bayer We Foster an Environment of Openness and Understanding Not Pity

Jürgen Schrapp, Bayer, Head of R&D Procurement

The Best Thing About Evotec, Without Question, Is The People

Stuart Flanagan, Evotec, Group Leader

View All Careers Articles

Headline News

Lilly’s releases statement on CMMI BALANCE model for GLP-1 medicines and medicare GLP-1 bridge model

Vertex releases positive interim analysis results for primary and all secondary endpoints in phase 3 trial of Povetacicept

GSK’s acquisition of RAPT Therapeutics

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Risk Assessment of Extractables and Leachables in Different Phases of Development.

Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals and Ward d’Autry, Study Director E/L & Structural Elucidation, Nelson Labs Europe
22nd April 2021

Hybrid Models: The Best of Both (Mechanistic & Empirical) Worlds to Accelerate and De-Risk Process Development

Presented by Christian Airiau, PhD, Global Head Data Sciences, Biologics Development at Sanofi and Chris McCready, Lead Data Scientist at Sartorius Stedim Biotech
16th March 2021

Regulatory Approval of Three Rapid Microbiological Methods for MACI Product Release

Presented by John Duguid Senior Director, Research & Development at Vericel Corporation and Nicola Reid, Senior Product Manager at Charles River
08th November 2018

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos